SCHEMBL4667063

SCHEMBL4667063

CCc1cc(-c2cc(N)n(-c3ccccc3C)n2)ccn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
MAPT P10636 6/20 0.61
RAB9A P51151 8/20 0.44
SMN1; SMN2 Q16637 8/20 0.44
NPC1 O15118 6/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 4/20 0.42
STAT1 P42224 1/20 0.41
MAP4K4 O95819 1/20 0.41
NR3C2 P08235 1/20 0.39
MTOR P42345 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1821288 0.79 ALDH1A1 (0.83) ALDH1A1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL1913687 0.76 MAPT (1.00) ALDH1A1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL3869440 0.74 MAPT (0.79) ALDH1A1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL28240672 0.74 MAPT (0.79) ALDH1A1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL4665900 0.72 ADORA1 (0.51) MAPTTP53
SCHEMBL4667040 0.71 ADORA1 (0.42) ALDH1A1MAPTKDM4ENR3C2TP53
SCHEMBL1143383 0.69 CYP1A2 (0.62) ALDH1A1MAPTRAB9ASMN1; SMN2L3MBTL1
SCHEMBL4665083 0.69 MAPT (0.46) ALDH1A1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL27836791 0.69 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ACYP1A2CYP2C19
Hydrochloric Acid SCHEMBL11473767 0.68 CYP1A2 (0.61) ALDH1A1MAPTRAB9ASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed